Chemo-Brain and ADT for Advanced Prostate Cancer – Does It Exist?

When I went on my first round of hormone therapy (ADT) I experienced severe cognitive side effects. I found it impossible to concentrate, read and remember anything. I lost the ability to navigate the New York City subways no less drive my car to a destination. Occasionally, when I was attempting to navigate the subway [...]

Bone Metastases and Prostate Cancer

The vast majority of men with advanced prostate cancer will eventually develop bone metastases. Given this fact it is important to understand what is meant by the term bone metastases. Bones serve as the supporting framework of our bodies. Like the rest of us bones are constructed of cells. These cells compose a network or [...]

ASCO 2014 – Exercise Cuts Cytokines in Prostate Cancer

Research released at the ASCO meeting in Chicago confirms that regular exercise is a must for men with advanced prostate cancer.  It was found that a regular and  structured physical exercise program reduces cytokine production which is related to depression and  to the inflammatory processes.  According to the researchers these factors may impact prostate cancer [...]

Denosumab is Superior to Zoledronic Acid (ZA) for Pain Interference and Quality of Life

Men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) will eventually develop debilitating pain that impacts daily functioning and diminishes their quality of life. Based on prior studies, including a phase III trial, the superiority of denosumab over zoledronic acid (ZA) in delaying or preventing skeletal-related events (pathological fracture, radiation or surgery to the [...]

Cancer Depression – No Denying It Haunts Us All

We all are subject to developing depression and prostate cancer survivors are subject to a large share of it.  Besides dealing with the everyday issues of living our life, we also are hounded by our diagnosis.   However, it is important to understand that there are everyday types of depression and what is referred to as [...]

Go to Top